geovax.com - GOVX Total Company Value
GeoVax Labs, Inc. (GOVX) operations rely on stable support from US government grants and an absence of sanctions risks. A team of leading immunologists and virologists is striving to create treatments against dangerous infections. This chart of the share price on GURU.Markets shows an Enterprise Value of -0.82. Business revenues will be based on the commercialization of cancer and Zika virus treatments via the MVA system.
GeoVax Labs, Inc. (GOVX) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- business book valuation details:
- company total debt and liquidity indicators:
- earnings and valuation multiples indicators:
Analysis of all company metrics:GeoVax Labs
Enterprise Value determines the actual price for a full business buyout, stripping the valuation of speculative noise. The formula aggregates market capitalization and debt, subtracting cash to reveal the true capital. Analyzing the Enterprise Value forecast allows for the separation of temporary euphoria from long-term trends. This metric is critical for GeoVax Labs, Inc. (GOVX), whose value depends on the success of vaccine clinical trials. This helps assess the premium paid for future breakthroughs in immunotherapy.
Competitors of GeoVax Labs, Inc. (GOVX)
argenx N.V. (ARGX) - Total Enterprise Value|BNTX: Real Price to Acquire Entire Company|ABVX: Total Company Value|ADMA (ADMA Biologics) - Real Price to Acquire Entire Company|Business Value PTGX|Total Company Value Immunovant|Kiniksa Pharmaceuticals, Ltd. - Full Business Value|Enterprise Value GRFS|ADPT (Adaptive Biotechnologies Inc.) - Value Adjusted for Debt and Cash|Enterprise Value CLDX (Celldex Therapeutics)|Enterprise Value auriniapharma.com AUPH|BCRX - Total Company Value|Value Adjusted for Debt and Cash VERA (Vera Therapeutics Inc)|Dianthus Pharma (DNTH) - Total Company Value|Real Price to Acquire Entire Company Pharvaris Pharma|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com|Real Price to Acquire Entire Company PGEN (Precigen)|PHAR (Pharming Group NV) - Value Adjusted for Debt and Cash|Enterprise Value NKTR (Nektar)|Company Buyout Price Upstream Pharma (UPB)|ZBIO - Total Company Value|immunome.com (IMNM) - Real Price to Acquire Entire Company|Gossamer Bio (GOSS) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|Real Price to Acquire Entire Company SEPN|Enterprise Value Pieris Corp|Total Company Value Savara Inc. (SVRA)|rigel.com - Business Value|Enterprise Value ANAB (AnaptysBio)|Astria Therapeutics Inc (ATXS) - Total Enterprise Value|enGene Bio - Enterprise Value|Full Takeover Company Value RAPT Therapeutics Inc. (RAPT)|JBIO: Enterprise Value|Total Enterprise Value aclaristx.com (ACRS)|Total Company Value Kyverna Therapeutics, Inc.|Total Enterprise Value Tiziana Life Sciences Ltd. TLSA|Real Price to Acquire Entire Company CABA (Cabaletta Bio, Inc)|Total Company Value VTYX (Ventyx Biosciences, Inc)|Enterprise Value THTX (Theratechnologies Inc.)|Enterprise Value avalotx.com AVTX|ELDN: Real Price to Acquire Entire Company|AGEN (Agenus, Inc.) - Business Value|CLYM (Climb Bio, Inc.) - Real Price to Acquire Entire Company|Zura Bio Ltd - Value Adjusted for Debt and Cash|Total Company Value aTyr Pharma, Inc.|Total Company Value ADAG|Enterprise Value IMA|Enterprise Value shattucklabs.com (STTK)|Enterprise Value EQ (Equillium)|Connect Biopharma Holdings - Total Company Value|IMUX - Total Company Value|Company Buyout Price Atara Biotherapeutics ATRA|IFRX (inflarx.de) - Real Price to Acquire Entire Company|X4 Pharmaceuticals Inc. - Value Adjusted for Debt and Cash|ACET (Adicet Bio Inc.) - Enterprise Value|Celularity Corp (CELU) - Company Buyout Price|Total Company Value INmune Bio, Inc. (INMB)|barinthusbio.com - Business Value|Enterprise Value KZR (Kezar Life Sciences, Inc.)|SABS - Real Price to Acquire Entire Company|AKTX: Real Price to Acquire Entire Company|Company Buyout Price Enlivex Therapeutics ENLV|QTTB: Enterprise Value|Full Takeover Company Value edesabiotech.com EDSA|Total Company Value iBio|Total Enterprise Value Carisma Tx CARM|Real Price to Acquire Entire Company XTLB (XTL Biopharmaceuticals, Ltd.)|Total Company Value BOLT (boltbio.com)|HCW Biologics - Real Price to Acquire Entire Company|APVO: Business Value|AIM - Total Company Value|Full Business Value ADTX|GRI: Enterprise Value|XORTX Corp - Value Adjusted for Debt and Cash|HIND (Vyome Holdings Inc) - Enterprise Value|Enterprise Value revbiosciences.com|Total Company Value Indaptus Therapeutics, Inc. (INDP)|SCNI (Scinai Immunotherapeutics Ltd) - Value Adjusted for Debt and Cash|Total Company Value CalciMedica CALI|AFMD - Real Price to Acquire Entire Company|Allakos Therapeutics - Enterprise Value|HOOK - Enterprise Value|IGMS (igmbio.com) - Real Price to Acquire Entire Company|iTeos Therapeutics Inc - Value Adjusted for Debt and Cash|OCEA (Ocean Bio) - Enterprise Value|TC BioPharm Ltd (TCBP) - Company Buyout Price|Total Company Value Third Harmonic Bio (THRD)